Global Cancer Institute appoints co-chief medical officers
Global Cancer Institute has appointed two oncologists to serve as co-chief medical officers.
Don S. Dizon, MD, FACP, FASCO, and Ben Ho Park, MD, will be responsible for accelerating the nonprofit’s programs for underserved patients with cancer around the world.
Dizon is professor of medicine at Brown University, director of women’s cancers and director of hematology-oncology clinics at Lifespan Cancer Institute, and director of medical oncology at Rhode Island Hospital. He specializes in the treatment of breast and pelvic cancers.
Park is director of precision oncology, associate director for translational research and co-leader of the breast cancer research program at Vanderbilt-Ingram Cancer Center.
Dizon and Park previously led Global Cancer Institute (GCI) tumor boards, which help oncologists in developing countries connect with U.S. physicians via videoconference to discuss and get advice about challenging cases.
The institute also offers patient navigation programs, which help ensure patients have rapid access to treatment, and cancer databases that provide insights into sociodemographic characteristics, treatment choices and outcomes of patients in developing countries.
“We are very fortunate to have both Dr. Dizon and Dr. Park taking a more active role in driving GCI’s international programs,” Paul E. Goss, MD, PhD, FRCPC, FRCP (UK), founder and chairman of GCI, said in a press release. “The COVID-19 pandemic has widened the gap in access to cancer care in developing countries, making GCI’s work more important than ever. As GCI’s co-chief medical officers, Drs. Dizon and Park will play key roles in ensuring access to quality care for the world’s most disadvantaged.”